arrow
T

Thomas Hank

University of Heidelberg
H指数:25
被引数:2,403

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Tumor Location and Preoperative Biliary Stenting Shape Gut Microbiome Diversity in Pancreatic Cancer

肿瘤位置和术前胆管支架置入影响胰腺癌肠道微生物多样性

Cancers
IF4.4
2026-08-180
OA
ASO Visual Abstract: Neoadjuvant Treatment is a Risk Factor for Clinically Relevant Chyle Leak (ISGPS Grade B/C) after Pancreatic Cancer Resection: A Retrospective Cohort Study

ASO视觉摘要:新辅助治疗是胰腺癌切除术后临床相关乳糜漏(ISGPS B/C级)的风险因素:一项回顾性队列研究

2025-12-130
PRE
Neoadjuvant Treatment is a Risk Factor for Clinically Relevant Chyle Leak (ISGPS Grade B/C) After Pancreatic Cancer Resection: A Retrospective Cohort Study

新辅助治疗是胰腺癌切除术后临床相关乳糜漏(ISGPS Grade B/C)的风险因素:一项回顾性队列研究

2025-11-210
OAAI
Development and validation of the Massachusetts General Hospital/Memorial Sloan Kettering nomogram to predict overall survival of resected patients with pancreatic ductal adenocarcinoma treated with neoadjuvant therapy
SURGERY
IF2.7
2022-10-011
OAAI